tiprankstipranks
Actinium Pharmaceuticals (ATNM)
NYSE MKT:ATNM

Actinium Pharmaceuticals Financial Statements

Actinium Pharmaceuticals Financial Overview

Actinium Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-1.14; its P/E ratio is -4.36; Actinium Pharmaceuticals is scheduled to report earnings on August 9, 2019, and the estimated EPS forecast is $-1.35. See an overview of income statement, balance sheet, and cash flow financials.
Mar 22Dec 21Sep 21Jun 21Mar 21
Income Statement
Total Revenue$ 940.00K$ 23.00K$ 233.00K$ 266.00K$ 622.00K
Gross Profit$ ―$ ―$ ―$ ―$ ―
EBIT$ -5.16M$ -8.05M$ -6.47M$ -5.08M$ -5.37M
EBITDA$ -5.03M$ -7.91M$ -6.34M$ -4.95M$ -5.25M
Net Income Common Stockholders$ -5.13M$ -8.01M$ -6.42M$ -5.02M$ -5.32M
Balance Sheet
Cash, Cash Equivalents and Short-Term Investments$ 48.23M$ 63.56M$ 72.02M$ 72.25M$ 77.83M
Total Assets$ 74.56M$ 80.39M$ 84.48M$ 84.45M$ 75.10M
Total Debt$ 197.00K$ 310.00K$ 421.00K$ 509.00K$ 634.00K
Net Debt$ -48.04M$ -63.25M$ -71.60M$ -71.74M$ -77.19M
Total Liabilities$ 5.72M$ 6.84M$ 4.19M$ 3.96M$ 4.36M
Stockholders Equity$ 45.43M$ 61.32M$ 68.84M$ 70.74M$ 73.55M
Cash Flow
Free Cash Flow$ -5.79M$ -5.05M$ -5.66M$ -4.64M$ -5.65M
Operating Cash Flow$ -5.78M$ -5.05M$ -5.59M$ -4.58M$ -5.64M
Investing Cash Flow$ -7.00K$ 0.00$ -68.00K$ -61.00K$ -4.00K
Financing Cash Flow$ -22.00K$ 801.00K$ 5.78M$ 14.30M$ 14.34M
Currency in USD

Actinium Pharmaceuticals Earnings and Revenue History


Actinium Pharmaceuticals Debt to Assets


Actinium Pharmaceuticals Cash Flow


Actinium Pharmaceuticals Forecast EPS vs Actual EPS


What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis